Myeong-Ju Noh

Title: Myeong-Ju Noh: Innovator in Pneumococcal Vaccine Development

Introduction

Myeong-Ju Noh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology, particularly in the development of vaccines against pneumococcal diseases. With a total of 4 patents, his work has had a substantial impact on public health.

Latest Patents

One of Myeong-Ju Noh's latest patents is a polyvalent pneumococcal polysaccharide-protein conjugate composition. This immunogenic composition comprises 15 different polysaccharide-protein conjugates. Each conjugate includes a capsular polysaccharide prepared from different serotypes, which are conjugated to a carrier protein. The serotypes involved are 1, 2, 3, 4, 5, 6A, 6B, 7F, 9N, 9V, 14, 18C, 19A, 19F, and 23F. This innovative composition, formulated into a vaccine with an aluminum-based adjuvant, enhances the application range concerning pneumococcal diseases in infants and children.

Career Highlights

Myeong-Ju Noh has worked with notable companies in the biotechnology sector, including SK Chemicals Co., Ltd. and SK Bioscience Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of effective vaccines.

Collaborations

Throughout his career, Myeong-Ju Noh has collaborated with esteemed colleagues such as Jin-Hwan Shin and Mahn-Hoon Park. These partnerships have fostered innovation and have been instrumental in the success of his projects.

Conclusion

Myeong-Ju Noh's contributions to vaccine development, particularly in pneumococcal diseases, highlight his role as a key innovator in the field. His patents and collaborations reflect his commitment to improving public health through scientific advancements.